The Diabetes Research Center (DRC) focuses on developing new methods to treat, prevent, and ultimately cure diabetes and its complications. The DRC is a multidisciplinary operation with faculty researchers from UAB's schools of Health Professions, Medicine, and Public Health, among other units. It operates in collaboration with the UAB Comprehensive Diabetes Center to promote excellence in diabetes research and patient care. The DRC supports the areas of animal physiology, human biology and intervention and translational research. It is one of the NIDDK-sponsored diabetes research centers in the U.S. View publications funded by the DRC at PubMed website.
FDA approves oral version of weight-loss drug semaglutide, UAB researchers react
Garvey receives Gerald Reavan Distinguished Leader in Insulin Resistance Award
Who will benefit from new ‘game-changing’ weight-loss drug semaglutide?
Prevention Strategies ‘Critical’ as Diabetes Rates Rise in Patients With HIV
